Cannabis Law Report

MAY 29, 2022

8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. An IND will require a clinical trial protocol in which an Institutional Review Board (IRB) must review and monitor the welfare, rights, and privacy of human subjects in the clinical trial. DEA and the Controlled Substances Act.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

SpeedWeed

JULY 14, 2021

The bill would create a Community Reinvestment Grant Program aimed at reinvesting cannabis tax revenue in communities most hurt by the War on Drugs. The bill would also direct the federal Small Business Administration to create a Cannabis Opportunity Program. Take the DEA out of the cannabis law enforcement business.

Marijuana 52

Marijuana Banking Programs Policy 52

Puff Puff Post

APRIL 29, 2019

“Nobody wants to see someone in jail for a month for the wrong thing,” DEA spokeswoman Barbara Carreno said. To further complicate the issue, states that already have their own hemp programs must have them approved by the U.S. He declined to provide more information, citing his clients’ desire for privacy.

Hemp 94

Hemp Agriculture DEA THC 94

PrestoDoctor

JANUARY 14, 2020

Who Monitors This Program in Oklahoma? The Oklahoma Medical Marijuana Authority (OMMA) manages the MMJ program for the State of Oklahoma. This agency oversees licensing, regulation, and administration of the program. The DEA does not know who has MMJs and no consolidated database exists. Will I Be Put on a List?

Marijuana 52

Marijuana Patients Conditions Programs 52

PrestoDoctor

JANUARY 14, 2020

Who Monitors This Program in Oklahoma? The Oklahoma Medical Marijuana Authority (OMMA) manages the MMJ program for the State of Oklahoma. This agency oversees licensing, regulation, and administration of the program. The DEA does not know who has MMJs and no consolidated database exists. Will I Be Put on a List?

Marijuana 52

Marijuana Patients Conditions Programs 52

CannaMD

SEPTEMBER 15, 2020

The governor also signed Senate Bill 1700 to protect the privacy of doctors recommending low-THC marijuana and their patients. In practice, the chances of feds or the DEA sitting at the border waiting to catch someone – that’s just not happening. In practice, however, it’s very ambiguous. It’s not practical or worth their time.

Law 126

Law Marijuana Patients Treatment 126